Table 2

Acute studies of exercise and adiponectin

SubjectsAcute exerciseAdiponectin (mg/ml)
Citationn, genderGroupIntensityDurationPrePostp Value
Short-term exercise (<60 min)
 Jürimäe et al7910 mElite rowersMaximal 6000 m rowingApproximately 20 min6.2 (9.5)0 min 5.7 (8.9)NS
30 min +19.3%p<0.05
Corrected for plasmavolume
6.2 (9.5)0 min 5.5 (8.5)p<0.05
30 min +20.0%p<0.05
 Jürimäe et al808 mTrained rowers6.5 km rowing at individual anaerobic thresholdApproximately13.2 (7.8)0 min 30 min 25.9 (10.6)NS
30 min 26.6 (9.3)p<0.05
 Jamurtas et al819 mOverweightCycling at 65% of VO2max45 min3.6 (0.7)0 min 3.2 (0.45)NS
 Kraemer et al826 mHealthyRunning at 79% of VO2max30 min7.45 (1.10)0 min 8.18 (1.20)p<0.05
Corrected for plasmavolumeNS
30 min 7.40 (1.05)NS
Long-term exercise (≥60 min)
 Ferguson et al.838 mHealthy, moderately activeCycling at 60% VO2max60 minm: 16.4 (4.5)0 min
8 ff: 19.3 (6.8)m: 18.8 (9.9)NS
f: 20 (7.9)NS
Corrected for plasmavolume
m: 16.4 (4.5)0 min
f: 19.3 (6.8)m: 16.2 (8.5)NS
f: 17.6 (6.2)NS
 Punyadeera et al8410 mActive (LFA)Cycling at 50% of VO2max120 min6.63 (0.8)30 min 6.2 (0.7)NS
Active (HFA)6.57 (0.7)30 min 6.1 (0.7)NS
  • Results are reported as mean (SD). p Values are reported for pre- versus post values.

  • F, female; HFA, high fatty acid (fasting condition); LFA, low fatty acid trial (following pharmacological inhibition of adipose tissue lipolysis); m, male; NS, not significant; VO2max, maximal oxygen uptake.